EverSource Wealth Advisors’s Avidity Biosciences RNAM Stock Holding History

EverSource Wealth Advisors’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-121	Closed	-$8.73K	–	4485
2025 Q4	$8.73K	Sell	121 -19	-14%	-$1.23K	﹤0.01%	2867
2025 Q3	$6.1K	Buy	140 +6	+4%	+$243	﹤0.01%	3072
2025 Q2	$3.81K	Buy	134 +84	+168%	+$2.5K	﹤0.01%	3271
2025 Q1	$1.48K	Buy	50 +3	+6%	+$93	﹤0.01%	3076
2024 Q4	$1.37K	Buy	47 +25	+114%	+$1.04K	﹤0.01%	2862
2024 Q3	$1.01K	Buy	+22	New	+$955	﹤0.01%	2730

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

EverSource Wealth Advisors's RNAM Position: Q1 2026 in Review

EverSource Wealth Advisors sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 121 shares — an estimated $8.73K sold.

EverSource Wealth Advisors first reported a position in RNAM in Q3 2024 and held it in 6 quarters. The position peaked at $8.73K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

EverSource Wealth Advisors reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
EverSource Wealth Advisors sold 121 Avidity Biosciences shares in Q1 2026, an estimated $8.73K.
EverSource Wealth Advisors first reported a position in Avidity Biosciences in Q3 2024 and held it in 6 quarters.
EverSource Wealth Advisors's Avidity Biosciences position peaked at $8.73K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.